Navigation Links
Self monitoring of blood glucose levels helps patients with diabetes
Date:10/1/2009

Los Angeles, London, New Delhi, Singapore and Washington DC (October 1, 2009) Self-monitoring of blood glucose (SMBG) enables those with diabetes to modify their behavior, adjust their medicine and understand their disease to better manage it, according to a recent study, published by SAGE in The Diabetes Educator. The research looked at "paired testing," a self-monitored testing both before and after specific events, to evaluate whether it could assist the patient in making better health and food choice decisions over time.

In the study, sponsored by Roche Diagnostics through an unrestricted educational grant, healthcare professionals from various medical specialties collaborated to review current research regarding the value and utility of SMBG and formulate professional opinions regarding its use. With the goal of encouraging patients' active involvement in the control of their own disease, instead of just blindly following the edicts of their healthcare providers, researchers found that paired testing can be helpful to:

  • provide immediate feedback regarding the impact of specific eating and exercise actions
  • assess critical nuances of the disease to help the patient make the very best choices
  • target specific meals to identify the impact of food choices on blood glucose levels
  • detect differences between weekend and weekday schedules and habits
  • learn what does and what does not work in the daily management of diabetes
  • facilitate positive and healthy patient self-care behaviors

"Although the utility of SMBG in non-insulin-treated Type 2 diabetes remains controversial," write the authors in the article, "a recent report from the International Diabetes Federation recommends SMBG use in this population if it is used to educate/motivate individuals and/or monitor and adjust therapy. Healthcare providers must develop strategies to utilize SMBG in ways that address these criteria."


'/>"/>

Contact: Jim Gilden
media.inquiries@sagepub.com
SAGE Publications
Source:Eurekalert

Page: 1

Related medicine news :

1. System Planning Corporation Launches New Asset Tracking and Monitoring System to Meet Pharmaceutical Industry Needs
2. IntegriChain Enlists Ed Casey and Associates to Drive Counterfeit and Diversion Monitoring Service
3. Transcutaneous cervical esophageal ultrasound can not substitute for 24-h pH monitoring or manometry
4. Axeda Selected for Remote Monitoring and Service of Automation Technologies
5. Singulex Announces Presentation on Monitoring of Cardiac Biomarker to Assess Transient Myocardial Ischemia at the American Heart Association Scientific Sessions
6. Novant Health(R) Selects Cardiocom(R) to Provide Telemonitoring for Presbyterian Hospital Heart Failure Program
7. Cavidi Signs Agreement With the Clinton Foundation HIV/AIDS Initiative to Lower Costs of HIV Monitoring
8. Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on the Release of the 2007 Monitoring the Future Study
9. Gary Tschautscher of Nonin Medical, Inc. Receives CEO of 2007 for North American Patient Monitoring From Frost & Sullivan
10. EaglePicher Technologies Introduces First Implantable Medical Cell Designed Specifically for Monitoring Applications
11. Bergen County (NJ) Early Adopter of Health Monitoring Systems Mergence(TM) Healthcare Data Integration Engine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... After suffering from women,s hair loss for almost... and she,s sharing her progress and the secret beh...ugh the release of her video diaries which include... her treatment. , (PRWeb ...ferer Zsanett Siklosi has released the video diari...
(Date:11/23/2009)...TargetIndividualsintheRecommendedPriorityGroups ,...--TheDepartmentofHealthannouncedtodaytheywillcondu...eHealthCentersinDelaware,Lancaster,andLehighcounti...inewillbeadministeredforfreetoindividualsinthereco...hevaccine.Thedepartmentasksthatonlyindividualsinth...
(Date:11/23/2009)...care professionals enjoy a pay raise for a job wel...s for health care performance may actually backfir... performance ratings for 25 medical groups across ...unch of a statewide pay-for-performance program in... productivity. , Reporting in the December ed...
(Date:11/23/2009)...t woman to head the agency, said lives could be at...s) -- The fallout from last week,s controversial r...e mammogram testing for breast cancer continues, w...of Health advising women to ignore the guidelines....ause unequivocally this will increase the number o...
(Date:11/23/2009)...caretofinance"reform"isamoraloutrage ,, WASHI...eDemocratsmovedforwardtobeginthedebateontheirhealt...pporterstronggrassrootssenioradvocacygroup,iscalli...testthemassivecutstoMedicare.RetireSafePresidentTh...issuesliketaxes,abortion,andimmigration,whilethesi...
Breaking Medicine News(10 mins):Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 3Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3Health News:RetireSafe Calls on Seniors to Grab their Bullhorns to Save Medicare from Rationed Care 2
...enwood Systems, LLC ( http://www.GlenwoodSystems.c...h seamlessly integrates EMR and Practice Manage...ess. The product has been designed to reduce the ... Waterbury, CT (Vocus) February 26...
... affordable High Voltage Piezo Amplifier (QPA200) ...l applications, and to facilitate transducer evalu... Medford, MA (PRWEB) February 26, 2009 -- P...coustically cancel noise, or to replace solenoid v...
...n the retina that is responsible for maintaining t...as been imaged in a living retina for the first ti...yer could help doctors identify the onset of many ... ., "Our goal is to figure out why macular degene...
...harmaNet Development Group, Inc. (the "Company") (...evelopment services, today reported preliminary ne... 2008, of $1.6 million, or $0.08 per diluted share...provided in this press release is subject to recor...
...or February 26, 2009 at 10:00 a.m. EST , , , EA...ls, Inc. (Nasdaq: SVNT ) today reported financia...mber 31, 2008. For the fourth quarter of 2008, th...ad a net loss of $84.2 million, or $1.57 per share...
...ookings and continued positive cash flow from oper... AMCS ), a leader in radiology and medical image...ted unaudited financial results for the fourth qua...evenue : Total revenue for the fourth quarter of 2...
Other Medicine News:Health News:Glenwood Systems, LLC Improves Medical Billing Process with GlaceComplete 2Health News:Glenwood Systems, LLC Improves Medical Billing Process with GlaceComplete 3Health News:Amped Up Piezos Are On The Move - Driving Piezos with an Affordable High Voltage Piezo Amplifier QPA200 2Health News:Amped Up Piezos Are On The Move - Driving Piezos with an Affordable High Voltage Piezo Amplifier QPA200 3Health News:'Dark cells' of living retina imaged for the first time 2Health News:'Dark cells' of living retina imaged for the first time 3Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 2Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 3Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 4Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 5Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 6Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 7Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 8Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 9Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 10Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 11Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 12Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 13Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 14Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 15Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 16Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 17Health News:Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results 2Health News:Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results 3Health News:Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results 4Health News:Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results 5Health News:Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results 6Health News:Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results 7Health News:Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results 8Health News:Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results 9Health News:AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31, 2008 2Health News:AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31, 2008 3Health News:AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31, 2008 4Health News:AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31, 2008 5Health News:AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31, 2008 6
(Date:11/23/2009)...PRNewswire/--BioTrendsResearchGroup,Inc.releasedWa...esecondinamulti-phasesyndicatedmarketresearchproje...me,throughthefirstsixmonthsofproductavailability.E...rom50uniqueNephrologistsandqualitativeinformationf...me,obstaclestouse,reasonstouse,typicalpatienttypes...
(Date:11/23/2009)...23/PRNewswire/--AMDLASERSannouncedthisweekthatitco...artneringwithprestigiousindustry-leaderDr.LarryRos...llbetheexclusivesofttissuediodelaserusedduringalli...tothetop2%ofdentists. ,, (Photo: http://www.new...iswithgreatpleasurethatIproudlyannounceourpartners...
(Date:11/23/2009)....23/PRNewswire-FirstCall/--RaptorPharmaceuticalCor...uncedthepresentationofclinicaltrialdataonNGX426,th...tereceptorantagonist,atthe12thInternationalConfere...ldonNovember20-21inSanFrancisco.Theresultsofthestu...siologyattheCenterforPainMedicineoftheUniversityof...
Breaking Medicine Technology:Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2AMD LASERS Announces New Partnership with Dr. Larry Rosenthal and Aesthetic Advantage 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5Surgery Better Than Angioplasty for Narrowed Neck Artery 55646 1Surgery Better Than Angioplasty for Narrowed Neck Artery 55646 2Surgery Better Than Angioplasty for Narrowed Neck Artery 55646 3Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 1Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 2Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 3Dementia More Likely With One Subtype of HIV 55639 1
...EGF Antibodies Inhibited Tumor Growth By, ..., - Peregrine,s Antibodies that Selectively Inhibi...ges over Non-Selective Approaches - , - These Resu...ibody Support , Advancing Peregrine,s Anti-VEGF Pr...TUSTIN, Calif., April 16, 2007,/PRNewswire-FirstCa...
...ing, BLOOMFIELD, N.J., April 16, 2007 /PRNewswire-... that in vivo and in vitro,preclinical data presen...ncer Research (AACR) Annual Meeting show that ONCO...wth of non-small cell,lung cancer (NSCLC) and brea... apoptosis and reduced lactate,levels by ranpirnas...
Other Medicine Technology:Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 2Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 3Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 4Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 5Preclinical Data Show Alfacell's Onconase Inhibits Tumor Growth of,Non-Small Cell Lung Cancer, Breast Cancer Cells 2Preclinical Data Show Alfacell's Onconase Inhibits Tumor Growth of,Non-Small Cell Lung Cancer, Breast Cancer Cells 3
Gentamicin, 50 mg/ml
GENTAMICIN SULFATE, 1000X
...e is effective against gram positive and gram nega...ng with bacterial protein synthesis by binding to ...g concentration of 50 mg/L is generally non-toxic ...entler alternative to penicillin and steptomycin. ...
Gibco Gentamicin Reagent Solution (10 mg/ml) liquid
Medicine Products: